FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News

New Zealand Detects First H5N1 Bird Flu Case, Starts Vaccination Of Endangered Species

New Zealand reported its first case of the deadly H5N1 bird flu after a migratory seabird found on a beach near the capital, Wellington, tested positive, ⁠Biosecurity...

Clean Catheterization Matches Sterile for Related UTI Risk

A clean bladder catheterization technique is as effective as a sterile method.

Immunosuppression Shows No Survival Benefit in Nephropathy

Escalating immunosuppressive therapy is not associated with improved renal or patient survival in rapidly progressive secondary IgA nephropathy, a Spanish study finds.

Patients With Dermatomyositis May Develop Heart Rate Issues

A small subset of patients — primarily women — with dermatomyositis may develop postural orthostatic tachycardia syndrome years later, a study finds.

Weighted Flare Score Predicts Organ Damage Risk in Lupus

A novel weighted flare score for systemic lupus erythematosus identifies high-risk disease flares, which are linked to the risk for subsequent organ damage.

Which Factors Affect Quality of Life in Chronic Pruritus

Daily itch duration, sleep disturbance, scratching frequency, and average itch intensity mediate the link between disease severity and quality-of-life impairment in patients with pruritic dermatoses.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Todays Updates

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

Programs offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.

Germline Profiling May Improve Risk Stratification in t-MNs

A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.

Latest News

New Zealand reported its first case of the deadly H5N1 bird flu after a migratory seabird found on a beach near the capital, Wellington, tested positive, ⁠Biosecurity...

A clean bladder catheterization technique is as effective as a sterile method.

Escalating immunosuppressive therapy is not associated with improved renal or patient survival in rapidly progressive secondary IgA nephropathy, a Spanish study finds.

A small subset of patients — primarily women — with dermatomyositis may develop postural orthostatic tachycardia syndrome years later, a study finds.

A novel weighted flare score for systemic lupus erythematosus identifies high-risk disease flares, which are linked to the risk for subsequent organ damage.

Daily itch duration, sleep disturbance, scratching frequency, and average itch intensity mediate the link between disease severity and quality-of-life impairment in patients with pruritic dermatoses.

News All Time

Risk Stratification May ID Paraneoplastic Dermatomyositis

Paraneoplastic disease develops in a small proportion of patients with dermatomyositis but occurs mainly among those classified into the high-risk group per international risk stratification criteria.

A New Class of Therapeutics Could End Immunosuppressants

Amid growing evidence and a Nobel Prize win, research on regulatory T cells could transform treatment for autoimmune disease and transplant rejection, among many other conditions.

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century.

Physical, Mental Factors Decrease COPD Inhaler Technique

Breath holding optimizes inhaler use regardless of dexterity or cognition challenges.

Does Cancer Death Risk Increase After Transplantation?

De novo cancer may double the risk for long-term mortality among solid organ transplantation recipients, a population-based study shows.

Elevated Interferon Alfa May Reveal Sjögren Disease Subtype

Elevated interferon alfa levels mark a subgroup of Sjögren disease, revealing immune changes years before diagnosis, and mice studies mirror these findings.

Cancer Recurrence: What Awakens Dormant Tumor Cells?

Emerging therapies target dormant tumor cells and their microenvironment to delay or prevent metastatic recurrence after successful cancer treatment.

Autoimmune Diseases Respond to Teclistamab but With Risks

Teclistamab may have potential for clinical responses in patients with refractory autoimmune diseases; however, cytokine release syndrome and infections occur frequently.

Expanded Pediatric Use for Roflumilast Under FDA Review

If approved, topical roflumilast 0.05% will be approved for treating atopic dermatitis down to age 3 months.

Model Spots Kids With Anaphylaxis Who Do Not Require ED Care

A prediction model identifies children with anaphylaxis who are at a low risk of requiring additional epinephrine and may safely avoid visits to the emergency department.

What's Really Killing Patients With Late-Stage PD?

A decade-long study finds aspiration pneumonia as the leading cause of death in late-stage Parkinson's disease, and worsening motor function, cognition, and depression predict a higher risk for death.

Inside Isolation Units for Highly Contagious Diseases

The Spanish model highlights the infrastructure, training, and containment measures required for high-risk infectious disease care.

Lower Breathing Pressure Tied to Complications in Preemies

In premature babies, lower breathing pressure at birth is linked to a higher likelihood of needing a breathing tube and later lung and eye complications.

Education Nudges Patients With CKD Away From Haemodialysis

Structured predialysis education may help patients with chronic kidney disease stages 4 and 5 to choose peritoneal dialysis over haemodialysis, a Polish study finds.

Trump CDC Nominee Schwartz Set for July 15 US Senate Confirmation Hearing

Erica Schwartz, President Donald Trump's nominee to lead the U.S. Centers for Disease Control and Prevention, will appear before the Senate Committee on Health, Education,...

Children With Sesame Allergy Often Tolerate Intact Seeds

Most children with sesame allergy who develop reactions to concentrated sesame products tolerate whole seeds during supervised oral food challenge, supporting individualized dietary counseling.

Recommended News For You

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

Improved end-of-life conversations for cancer patients are identified by a new study.

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

Skinny melanoma incidence is associated with vitamin D deficiency.

Big Drop in Cervical Cancer Deaths; Publication Hijackers; A Win for CRC Home Tests

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

Recommended Articles For You

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer 

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies 

CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review 

Adaptive Rehabilitation Frameworks for Complex Cancer Survivorship 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

2.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

3.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

4.

New analysis helps discern benign from malignant thyroid growths

5.

"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.

1.

Environmental Carcinogen Avoidance in Precision Prevention

2.

The Ins and Outs of Glossectomy: What You Need to Know 

3.

How Cancer Cells Evade Immune Destruction and the Fight Back

4.

Understanding Phyllodes Tumor: Symptoms, Diagnosis, and Treatment Options

5.

Essential Strategies in Hematology for Healthcare Excellence

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

4.

Should We Use DARA Up Front As First-Line Therapy in MM?

5.

Efficient Management of First line ALK-rearranged NSCLC - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot